MTDH inhibits CrAT to promote mitochondrial damage in palmitic acid-induced renal tubular cells.

IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Shan-Fen Lan, Zhen-Hua Yang, Li Feng, Yu-Ting Wen, Kun-Ni Chen, Lang-Lin Fan, Ming-Jun Wang, Wen-Ting Liu
{"title":"MTDH inhibits CrAT to promote mitochondrial damage in palmitic acid-induced renal tubular cells.","authors":"Shan-Fen Lan, Zhen-Hua Yang, Li Feng, Yu-Ting Wen, Kun-Ni Chen, Lang-Lin Fan, Ming-Jun Wang, Wen-Ting Liu","doi":"10.1007/s00592-025-02476-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Mitochondrial dysfunction leading to impaired energy metabolism has been recognized as a pivotal factor contributing to renal tubular epithelial cells (RTECs) damage in the context of dyslipidemia conditions in diabetic kidney disease (DKD). The primary objective of this study is to elucidate the role and underlying mechanism of the proto-oncogene Metadherin (MTDH) in mediating mitochondrial damage within this specific pathological context in vitro.</p><p><strong>Methods: </strong>The expression of MTDH in RTECs was modulated by transfecting small interfering RNA and plasmid, while palmitic acid (PA) was employed to simulate diabetic lipid metabolism disorder. Mitochondrial damage was evaluated by examining various parameters including mitochondrial morphology, membrane potential, reactive oxygen species (ROS) production, adenosine triphosphate (ATP) production, as well as morphological and structural alterations. Additionally, Carnitine acetyltransferase (CrAT) expression was assessed using Western blotting and quantitative real-time polymerase chain reaction, and CrAT activity was quantified.</p><p><strong>Result: </strong>MTDH expression was upregulated in PA-induced RTECs, while CrAT expression and activity were inhibited. Downregulation of MTDH mitigated PA-induced mitochondrial damage, as demonstrated by the preservation of mitochondrial membrane potential, reduction in mitochondrial ROS production, prevention of ATP depletion, and maintenance of mitochondrial structure. This was accompanied by an upregulation in CrAT expression and activity. Conversely, overexpression of MTDH exacerbated mitochondrial dysfunction by impairing membrane potential, augmenting mitochondrial ROS production, inhibiting ATP synthesis, and suppressing CrAT expression and activity.</p><p><strong>Conclusion: </strong>In the context of dyslipidemia conditions, MTDH is upregulated and suppresses the expression and activity of CrAT in RTECs, thereby inducing mitochondrial dysfunction and perturbing energy metabolism. These alterations exacerbate the injury to RTECs, consequently promoting the progression of DKD.</p>","PeriodicalId":6921,"journal":{"name":"Acta Diabetologica","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Diabetologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00592-025-02476-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Mitochondrial dysfunction leading to impaired energy metabolism has been recognized as a pivotal factor contributing to renal tubular epithelial cells (RTECs) damage in the context of dyslipidemia conditions in diabetic kidney disease (DKD). The primary objective of this study is to elucidate the role and underlying mechanism of the proto-oncogene Metadherin (MTDH) in mediating mitochondrial damage within this specific pathological context in vitro.

Methods: The expression of MTDH in RTECs was modulated by transfecting small interfering RNA and plasmid, while palmitic acid (PA) was employed to simulate diabetic lipid metabolism disorder. Mitochondrial damage was evaluated by examining various parameters including mitochondrial morphology, membrane potential, reactive oxygen species (ROS) production, adenosine triphosphate (ATP) production, as well as morphological and structural alterations. Additionally, Carnitine acetyltransferase (CrAT) expression was assessed using Western blotting and quantitative real-time polymerase chain reaction, and CrAT activity was quantified.

Result: MTDH expression was upregulated in PA-induced RTECs, while CrAT expression and activity were inhibited. Downregulation of MTDH mitigated PA-induced mitochondrial damage, as demonstrated by the preservation of mitochondrial membrane potential, reduction in mitochondrial ROS production, prevention of ATP depletion, and maintenance of mitochondrial structure. This was accompanied by an upregulation in CrAT expression and activity. Conversely, overexpression of MTDH exacerbated mitochondrial dysfunction by impairing membrane potential, augmenting mitochondrial ROS production, inhibiting ATP synthesis, and suppressing CrAT expression and activity.

Conclusion: In the context of dyslipidemia conditions, MTDH is upregulated and suppresses the expression and activity of CrAT in RTECs, thereby inducing mitochondrial dysfunction and perturbing energy metabolism. These alterations exacerbate the injury to RTECs, consequently promoting the progression of DKD.

MTDH抑制CrAT促进棕榈酸诱导的肾小管细胞线粒体损伤。
目的:线粒体功能障碍导致能量代谢受损已被认为是糖尿病肾病(DKD)中血脂异常情况下肾小管上皮细胞(RTECs)损伤的关键因素。本研究的主要目的是阐明原癌基因Metadherin (MTDH)在体外特定病理环境下介导线粒体损伤的作用和潜在机制。方法:通过转染小干扰RNA和质粒调节RTECs中MTDH的表达,同时采用棕榈酸(PA)模拟糖尿病脂质代谢紊乱。通过检测线粒体形态、膜电位、活性氧(ROS)产生、三磷酸腺苷(ATP)产生以及形态和结构改变等各种参数来评估线粒体损伤。此外,采用Western blotting和实时定量聚合酶链反应检测肉碱乙酰转移酶(Carnitine acetyltransferase, CrAT)的表达,并测定CrAT活性。结果:在pa诱导的RTECs中,MTDH表达上调,CrAT表达和活性受到抑制。MTDH的下调减轻了pa诱导的线粒体损伤,这可以通过保存线粒体膜电位、减少线粒体ROS产生、防止ATP耗尽和维持线粒体结构来证明。这伴随着CrAT表达和活性的上调。相反,过表达MTDH会通过损害膜电位、增加线粒体ROS的产生、抑制ATP合成和抑制CrAT的表达和活性而加剧线粒体功能障碍。结论:在血脂异常的情况下,MTDH上调,抑制rtec中CrAT的表达和活性,从而诱导线粒体功能障碍,扰乱能量代谢。这些改变加剧了rtec的损伤,从而促进了DKD的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Diabetologica
Acta Diabetologica 医学-内分泌学与代谢
CiteScore
7.30
自引率
2.60%
发文量
180
审稿时长
2 months
期刊介绍: Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信